Literature DB >> 16186529

Natural history of primary progressive aphasia.

Emilie Le Rhun1, Florence Richard, Florence Pasquier.   

Abstract

OBJECTIVE: To characterize the natural history of primary progressive aphasia (PPA).
METHODS: Forty-nine patients (28 women) with newly diagnosed with PPA presenting to a memory disorders clinic between 1992 and 2001 were prospectively evaluated.
RESULTS: Median age at onset was 62 years (range 49 to 73 years) and at first visit was 66 years (52 to 80 years). The median duration of follow-up was 4 years (1 to 11 years). Impairments in activities of daily living developed a median of 6 to 7 (2 to 12) years post onset. Seventy-five percent of patients eventually met clinical diagnostic criteria for frontotemporal dementia (FTD), 14% met diagnostic criteria for dementia with Lewy bodies, and 8% developed signs of corticobasal degeneration; 60% of the patients died after a median course of 7 years (3 to 17 years) at a median age of 71 years (56 to 81 years). Patients showing high Mini-Mental State Examination scores, moderate aphasia, and fluent language at first visit subsequently retained greater autonomy in daily life.
CONCLUSIONS: Although activities of daily living are well maintained during the first years of the disease, patients with primary progressive aphasia (PPA) may lose autonomy 6 to 7 years after onset. The majority of patients with PPA in the current study developed frontotemporal dementia.

Entities:  

Mesh:

Year:  2005        PMID: 16186529     DOI: 10.1212/01.wnl.0000175982.57472.84

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  What is the life expectancy in frontotemporal lobar degeneration?

Authors:  Chiadi U Onyike
Journal:  Neuroepidemiology       Date:  2011-11-02       Impact factor: 3.282

2.  Quantitative classification of primary progressive aphasia at early and mild impairment stages.

Authors:  M-Marsel Mesulam; Christina Wieneke; Cynthia Thompson; Emily Rogalski; Sandra Weintraub
Journal:  Brain       Date:  2012-04-23       Impact factor: 13.501

3.  Visual and statistical analysis of ¹⁸F-FDG PET in primary progressive aphasia.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; María Jesús Pérez-Castejón; Teresa Moreno-Ramos; Cristina Rodríguez-Rey; Rocío García-Ramos; Aida Ortega-Candil; Marta Fernandez-Matarrubia; Celia Oreja-Guevara; Jorge Matías-Guiu; José Luis Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

Review 4.  Quantitating severity and progression in primary progressive aphasia.

Authors:  Bradford C Dickerson
Journal:  J Mol Neurosci       Date:  2011-05-15       Impact factor: 3.444

Review 5.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

6.  Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.

Authors:  Jordi A Matias-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; Rocío García-Ramos; Jesús Porta-Etessam; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

7.  Estimating severity of illness and disability in Frontotemporal Dementia: Preliminary analysis of the Dementia Disability Rating (DDR).

Authors:  Chiadi U Onyike; Kelly L Sloane; Shawn F Smyth; Brian S Appleby; David M Blass; Peter V Rabins
Journal:  Acta Neuropsychol       Date:  2011

Review 8.  [Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Authors:  I Liepelt; W Maetzler; H-P Blaicher; T Gasser; D Berg
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

9.  Patterns of Decline in Naming and Semantic Knowledge in Primary Progressive Aphasia.

Authors:  Rajani Sebastian; Carol B Thompson; Nae-Yuh Wang; Amy Wright; Aaron Meyer; Rhonda B Friedman; Argye E Hillis; Donna C Tippett
Journal:  Aphasiology       Date:  2018-06-28       Impact factor: 2.773

Review 10.  Pharmacotherapy for Frontotemporal Dementia.

Authors:  Rita Khoury; Yu Liu; Quratulanne Sheheryar; George T Grossberg
Journal:  CNS Drugs       Date:  2021-04-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.